CJC-1295 with DAC 5mg
CJC-1295 with DAC (Drug Affinity Complex) is a long-acting GHRH analog. The DAC conjugation binds to albumin in vivo, extending the half-life from minutes to approximately 8 days. Clinical research demonstrates sustained elevations in GH and IGF-1 levels for up to 2 weeks after a single injection.
Sequence
GHRH(1-29)-NH2 with Drug Affinity Complex (DAC) conjugation
Market avg: $54.99 — save 31%
Volume pricing
Pay with USDC via Coinbase Commerce
Certificate of Analysis
Independently verified by Janoshik Analytical
Test ID
JAN-CJC1295DAC-2026-001
Purity
99%
Method
HPLC-MS
Batch
CJCDAC-2026-01A
Test Date
February 1, 2026
Identity
Confirmed
Storage Requirements
Lyophilized
2-8°C, protect from light
Reconstituted
2-8°C, use within 14 days
The DAC moiety extends half-life to ~8 days. Produces sustained GH elevation rather than pulsatile release.
Published Research
1 peer-reviewed studies
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295
Teichman SL, Neale A, Lawrence B, et al. — Journal of Clinical Endocrinology & Metabolism, 2006
Clinical study demonstrating dose-dependent, sustained increases in GH and IGF-1 following CJC-1295 with DAC.
Related Products
CJC-1295 no DAC 2mg
GHRP-6 5mg
Ipamorelin 5mg
CJC-1295 + Ipamorelin Blend 10mg
GHRP-2 5mg
Hexarelin 2mg
Sermorelin 5mg
Tesamorelin 5mg
Kisspeptin-10 5mg
Research use only. All products are sold strictly for in-vitro research purposes only. Not for human consumption. Information provided references published research literature. No medical claims are made or implied.